Citation Impact
Citing Papers
Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor β–Insensitive CD8+ T Cells
2009
Phase I Trial of the Novel Mammalian Target of Rapamycin Inhibitor Deforolimus (AP23573; MK-8669) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients With Advanced Malignancies
2008
Biologic Differences Between Noninvasive Papillary Urothelial Neoplasms of Low Malignant Potential and Low-Grade (Grade 1) Papillary Carcinomas of the Bladder
2001
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
2014 Standout
The effects of oxidative stress on female reproduction: a review
2012 Standout
MMP-2 Protein in Invasive Breast Cancer and the Impact of MMP-2/TIMP-2 Phenotype on Overall Survival
2003
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
2014 Standout
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
2008 StandoutNobel
Spermatogenesis in fish
2009 Standout
Evaluation of hypoxia‐inducible factor 1α overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma
2005
Natural products: An evolving role in future drug discovery
2011 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract
2004
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Oxidative Stress, Spermatogenesis and Fertility
2002
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)
2012
Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma
2011
Normal and neoplastic urothelial stem cells: getting to the root of the problem
2012
Post-therapy Serum Prostate-Specific Antigen Level and Survival in Patients With Androgen-Independent Prostate Cancer
1999
The development of androgen-independent prostate cancer
2001 Standout
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
2017 Standout
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
2017 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen
2006
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
First- and Second-Line Therapy for Metastatic Urothelial Carcinoma of the Bladder
2011
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Infections in the male genital tract and reactive oxygen species
1999
Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus
1999
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours
2005
TGFβ in Cancer
2008 Standout
Role of reactive oxygen species in the pathophysiology of human reproduction
2003 Standout
Electrical, contractile and structural remodeling during atrial fibrillation
2002 Standout
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
2005
New Therapeutic Challenges in Advanced Bladder Cancer
2012
Current strategies in the management of hormone refractory prostate cancer
2003
Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 Standout
Development of novel therapeutic strategies that target HIF-1
2006 StandoutNobel
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Evaluation of HIF-1 inhibitors as anticancer agents
2007 StandoutNobel
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Myocardial cell death in fibrillating and dilated human right atria
1999
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Inflammation as a Risk Factor for Atrial Fibrillation
2003 Standout
The Balance between Life and Death of Cells: Roles of Metallothioneins.
2007
The Role of Perioperative Chemotherapy in the Treatment of Urothelial Cancer
2006
Hormone Resistance in Prostate Cancer
1998
Estrogen Metabolite 2-Methoxyestradiol Induces Apoptosis and Inhibits Cell Proliferation and Collagen Production in Rat and Human Leiomyoma Cells: A Potential Medicinal Treatment for Uterine Fibroids
2006 Standout
Bladder Cancer
2020 Standout
Oxidative stress & male infertility.
2009
Blockade of Platelet-Derived Growth Factor Receptor-Beta by CDP860, a Humanized, PEGylated di-Fab', Leads to Fluid Accumulation and Is Associated With Increased Tumor Vascularized Volume
2004
Identification and Prognostic Significance of an Epithelial-Mesenchymal Transition Expression Profile in Human Bladder Tumors
2007
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
The Balance between Life and Death of Cells: Roles of Metallothioneins
2006
The Effects of Cadmium Toxicity
2020 Standout
Molecular Mechanisms in Spermatogenesis
2008
Targeting Signal Transduction Pathways in Colorectal Cancer—More Than Skin Deep
2005
Biochemical and molecular evaluation of neutrophil NOS in spontaneously hypertensive rats.
2007
A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies
2008
p53 Immunohistochemistry as a Prognostic Marker in Bladder Cancer
2000
Bcl-2 Receptor Expression in Patients With Uterine Smooth Muscle Tumors: An Immunohistochemical Analysis Comparing Leiomyoma, Uterine Smooth Muscle Tumor of Uncertain Malignant Potential, and Leiomyosarcoma
2004
Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
2011
A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer
2007 StandoutNobel
Novel strategies and therapeutics for the treatment of prostate carcinoma
2000
TGF-β Promotes the Establishment of Renal Cell Carcinoma Bone Metastasis
2006
Regulation of angiogenesis by hypoxia-inducible factor 1
2006 StandoutNobel
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Anastasios Zervas being referenced
Expression of transforming growth factor ? in renal cell carcinoma and matched non-involved renal tissue
2004
Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: Comparison with dna ploidy
1995
Short‐ and long‐term complications of open radical prostatectomy according to the Clavien classification system
2008
The prevalence of bcl-2, p53, and ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates
1998
Oral estramustine and oral etoposide for hormone-refractory prostate cancer
1997
In vivo effect of the lipido-sterolic extract of Serenoa repens (Permixon) on mast cell accumulation and glandular epithelium trophism in the rat prostate
2002
Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: Association with differentiation, proliferation and clinical outcome
2008
Prognostic significance of metallothionein expression in renal cell carcinoma
2005
Nitric Oxide Synthase and Xanthine Oxidase Activities in the Spermatic Vein of Patients with Varicocele: A Potential Role for Nitric Oxide and Peroxynitrite in Sperm Dysfunction
1996
Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group
2003
Prognostic value of E-cadherin, beta-catenin, P120ctn in patients with transitional cell bladder cancer.
2001